The global macro-environment is evolving rapidly and already affecting decisions about launches, infrastructure investments, asset life-cycle management, trial design and more. Today, everyone in the pharma ecosystem has to be aware of the regulatory, policy and reimbursement changes that affect strategic decision-making. Join us as we dig into the trends that you should have on your radar today.
In this webinar, you’ll learn:
- Regulatory, policy and market access changes coming and their implications for pharma
- Scenarios that will affect decision-making about lead launches (indication and markets) and investment in data and evidence generation infrastructure
- How to plan for the coming changes and revisit your current portfolio strategy, including how to manage asset life cycles and approach business development and licensing
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
